Evidence map›Paper›PMID 42099666›Full record

ArticleIJID regions2026

From hepatitis A to acute liver failure in a resource-limited setting: a case report.

Isabel Cristina Plaza Dorante, Daniel Antonio Rodríguez-Sánchez, María Gracia Zabaleta Manzanillo, Darian Guadalupe Rodríguez Pérez, Ivana Belen Pimentel Delgado, Dylianis Chiquinquirá López Cepeda, Donny-Sabrith Solano-Jimenez, Ana-Karina Carbonell-Zabaleta, Dario S Lopez Delgado, Valmore Bermúdez

Abstract readCase Reports
In one paragraph

Article in IJID regions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Isabel Cristina Plaza DoranteEndocrine and Metabolic Diseases Research Center, Faculty of Medicine, School of Medicine, University of Zulia, Maracaibo, Venezuela.
Daniel Antonio Rodríguez-SánchezEndocrine and Metabolic Diseases Research Center, Faculty of Medicine, School of Medicine, University of Zulia, Maracaibo, Venezuela.
María Gracia Zabaleta ManzanilloEndocrine and Metabolic Diseases Research Center, Faculty of Medicine, School of Medicine, University of Zulia, Maracaibo, Venezuela.
Darian Guadalupe Rodríguez PérezEndocrine and Metabolic Diseases Research Center, Faculty of Medicine, School of Medicine, University of Zulia, Maracaibo, Venezuela.
Ivana Belen Pimentel DelgadoEndocrine and Metabolic Diseases Research Center, Faculty of Medicine, School of Medicine, University of Zulia, Maracaibo, Venezuela.
Dylianis Chiquinquirá López CepedaEndocrine and Metabolic Diseases Research Center, Faculty of Medicine, School of Medicine, University of Zulia, Maracaibo, Venezuela.
Donny-Sabrith Solano-JimenezEndocrine and Metabolic Diseases Research Center, Faculty of Medicine, School of Medicine, University of Zulia, Maracaibo, Venezuela.
Ana-Karina Carbonell-ZabaletaEndocrine and Metabolic Diseases Research Center, Faculty of Medicine, School of Medicine, University of Zulia, Maracaibo, Venezuela.
Dario S Lopez DelgadoHospital Departmental de Nariño, Department of Investigation, Pasto, Colombia.
Valmore BermúdezUniversidad Simón Bolívar, Facultad de Ciencias de la Salud, Centro de Investigaciones en Ciencias de la Vida, Barranquilla, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis A virus (HAV) infection is usually self-limited, but a minority of cases progress to acute liver failure (ALF), particularly, in resource-limited settings. We report a previously healthy 19-year-old woman who presented with 20 days of jaundice, dark urine, and hepatic encephalopathy. Baseline tests showed total bilirubin 18.3 mg/dL, aspartate aminotransferase 281 U/l, alanine aminotransferase 341 U/l, international normalized ratio (INR) 1.23, and positive anti-HAV immunoglobulin M/immunoglobulin G. Although she did not meet formal ALF criteria at presentation, within 72 hours, she progressed to ALF, with bilirubin rising to 28 mg/dL, INR to 1.8, and ammonia to 140 µg/dL; ultrasonography revealed hepatomegaly. In the absence of liver transplantation or continuous renal replacement therapy, a resource-adapted supportive bundle was implemented, including intravenous N-acetylcysteine, vitamin K, neuroprotection, glucose control, early enteral nutrition, conservative transfusion, and infection surveillance. Clinical and biochemical parameters improved, and she was discharged after approximately 4 weeks, with recovery on follow-up. This case highlights early warning signs and the feasibility of a structured non-transplant management pathway for HAV-associated ALF in constrained settings.

Indexed as

Acute liver failureHepatic encephalopathyHepatitis A virusN-acetylcysteineResource-limited settings

Identifiers

PMID42099666
PMCPMC13147410

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.